How deadly is Breast cancer?

Zenbateraino da hilgarria bularreko minbizia?

Bularreko minbizia gaixotasun larria da, eta hilgarria izan daiteke.

Mundu osoko emakumeen artean minbizi ohikoena da eta emakumeen minbiziaren heriotzaren bigarren arrazoi nagusia da.

American Cancer Society-ren arabera, 20220an, gutxi gorabehera 276.480 bularreko minbizi kasu berri diagnostikatu ziren emakumeetan Estatu Batuetan, eta 42.170 emakume inguru hil ziren bularreko minbiziaren ondorioz.

Hala ere, bularreko minbiziaren heriotza-tasa jaitsi egin da 1989tik, bularreko minbiziaren heriotza-tasa % 40 murriztu da 1989tik 2017ra, batez ere detekzio goiztiarrean eta tratamenduan egindako hobekuntzen ondorioz.

Bularreko minbiziaren ondorioz hiltzeko arriskua adinaren, diagnostikoaren fasearen eta bularreko minbiziaren motaren araberakoa da.

Detekzio goiztiarrak eta tratamenduak bizirauteko aukerak nabarmen hobetu ditzakete.

Erreferentziak

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

van Schoor G, Moss SM, Otten JD, Donders R, Paap E, den Heeten GJ, Holland R, Broeders MJ, Verbeek AL: Increasingly strong reduction in breast cancer mortality due to screening. Br J Cancer. 2011, 104 (6): 910-4.

DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL: Breast cancer statistics, 2019. CA Cancer J Clin. 2019, 69 (6): 438-451.

Icaza G, Núñez L, Bugueño H: [Epidemiological analysis of breast cancer mortality in women in Chile]. Rev Med Chil. 2017, 145 (1): 106-114.

Monticciolo DL, Newell MS, Hendrick RE, Helvie MA, Moy L, Monsees B, Kopans DB, Eby PR, Sickles EA: Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging. J Am Coll Radiol. 2017, 14 (9): 1137-1143.

Deaths from breast cancer--United States, 1991. MMWR Morb Mortal Wkly Rep. 1994, 43 (15): 273, 279-81.

Kuroishi T, Hirose K, Suzuki T, Tominaga S: Effectiveness of mass screening for breast cancer in Japan. Breast Cancer. 2000, 7 (1): 1-8.

Erantzukizunik ez: medikoak.

Webgune hau hezkuntza eta informazio helburuetarako bakarrik eskaintzen da eta ez du aholkularitza medikoa edo zerbitzu profesionalik eskaintzen.

Ematen den informazioa ez da osasun-arazo edo gaixotasun bat diagnostikatzeko edo tratatzeko erabili behar, eta aholku mediko pertsonala bilatzen dutenek baimendutako mediku batekin kontsultatu behar dute.

Kontuan izan galderen erantzunak sortzen dituen sare neuronalak ez duela zehaztasunik, batez ere, eduki numerikoari dagokionez. Adibidez, gaixotasun jakin bat duten pertsonen kopurua.

Beti bilatu zure medikuaren aholkua edo beste osasun-zerbitzu kualifikatu bat gaixotasun mediko bati buruz. Sekula ez baztertu aholku mediko profesionala edo atzeratu webgune honetan irakurri duzun zerbaitengatik. Larrialdi mediko bat izan dezakezula uste baduzu, deitu 911 edo joan berehala larrialdietako gelara. Webgune honek edo haren erabilerak ez du mediku-paziente harremana sortzen. Ez BioMedLibek, ez bere langileek, ez webgune honetako inork ez du inolako adierazpenik egiten, espresorik edo inpliziturik, hemen emandako informazioari edo haren erabilerari dagokionez.

Arduragabekeria: egile eskubideak

1998ko Digital Millennium Copyright Act-ek, 17 U.S.C. § 512 (DMCA) -k, egile eskubideen jabeek Interneten agertzen den materialak AEBetako egile eskubideen arabera dituzten eskubideak urratzen dituela uste duten errekurtsoak eskaintzen ditu.

Fede onez uste baduzu gure webgunearekin edo zerbitzuekin lotuta eskuragarri dagoen eduki edo material batek zure egile eskubideak urratzen dituela, zuk (edo zure agenteak) jakinarazpen bat bidal diezagukezu eduki edo materiala kentzeko edo sarbidea blokeatzeko eskatuz.

Jakinarazpenak idatziz bidali behar dira posta elektronikoz (ikus "Kontaktua" atala posta elektronikoaren helbideari buruz).

DMCAk eskatzen du egile eskubideak urratzeari buruzko jakinarazpenean honako informazioa jasotzea: (1) urratzeari buruzko lanaren deskribapena; (2) urratzeari buruzko edukiaren deskribapena eta eduki hori aurkitzea ahalbidetzeko behar beste informazio; (3) zure harremanetarako informazioa, zure helbidea, telefono zenbakia eta posta elektronikoaren helbidea barne; (4) zure adierazpena, sinesmen ona duzula, salatutako moduan dagoen edukia ez dela egile eskubideen jabeak, edo bere agenteak, edo edozein legearen eraginez baimenduta.

(5) zure adierazpen bat, zin faltsuaren zigorraren pean sinatua, jakinarazpenean dagoen informazioa zehatza dela eta urratu direla dioten egile eskubideak betearazteko eskumena duzula;

eta (6) egile eskubideen jabearen edo egile eskubideen jabearen izenean jarduteko baimena duen pertsonaren sinadura fisikoa edo elektronikoa.

Goian aipatutako informazio guztia ez emateak zure kexaren tramitazioa atzeratzea ekar dezake.

Harremanetan jartzea

Bidali iezaguzu mezu elektroniko bat edozein galdera edo iradokizunekin.

How deadly is breast cancer?

Breast cancer is a serious and potentially deadly disease.

It is the most common cancer among women worldwide and the second leading cause of cancer death in women.

According to the American Cancer Society, in 20220, an estimated 276,480 new cases of invasive breast cancer were diagnosed in women in the United States, and about 42,170 women in the U.S. died from breast cancer.

However, the death rate from breast cancer has been declining since 1989, with a 40% decrease in the breast cancer death rate from 1989 to 2017, largely due to improvements in early detection and treatment.

The risk of dying from breast cancer varies depending on factors such as age, stage at diagnosis, and the type of breast cancer.

Early detection and treatment can significantly improve the chances of survival.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.